NCT04788862View on ClinicalTrials.gov

A Study of Blood-stage Controlled Human Plasmodium Falciparum Malaria Infection in Tanzania

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 18, 2022

Primary Completion Date

February 24, 2023

Study Completion Date

February 24, 2023

Conditions
MalariaPlasmodium Falciparum
Interventions
BIOLOGICAL

P. falciparum infected erythrocytes

Chloroquine sensitive P. falciparum 3D7-infected red blood cells, thawed and prepared under strict aseptic conditions, will be used as a challenge agent.

Trial Locations (1)

Unknown

Ifakara Health Institute, Bagamoyo

All Listed Sponsors
collaborator

Ifakara Health Institute

OTHER

lead

University of Oxford

OTHER